Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Cardiff Oncology Inc (CRDF)

Cardiff Oncology Inc (CRDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Cardiff Oncology Announces New Patent with Claims for the Use of Onvansertib in Treating KRAS mutated mCRC GlobeNewswire - Tue Nov 19, 7:00AM CST

CRDF : 2.51 (-0.79%)
Cardiff Oncology: Q3 Earnings Snapshot AP - Thu Nov 7, 4:04PM CST

Cardiff Oncology: Q3 Earnings Snapshot

CRDF : 2.51 (-0.79%)
Cardiff Oncology Reports Third Quarter 2024 Results and Provides Business Update GlobeNewswire - Thu Nov 7, 3:05PM CST

CRDF : 2.51 (-0.79%)
Cardiff Oncology Announces Journal of Clinical Oncology Publication of Data from Phase 2 Trial in Second-line KRAS Mutant mCRC GlobeNewswire - Wed Oct 30, 3:30PM CDT

CRDF : 2.51 (-0.79%)
Cardiff Oncology: Q2 Earnings Snapshot AP - Thu Aug 8, 3:58PM CDT

Cardiff Oncology: Q2 Earnings Snapshot

CRDF : 2.51 (-0.79%)
Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036 FinancialNewsMedia - Thu May 9, 11:15AM CDT

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:ZLAB),(NASDAQ:NTBL),(NASDAQ:CRDF),(NYSE:JNJ) EQNX::TICKER_END

ONCY : 0.9863 (-1.22%)
ONC.TO : 1.39 (-0.71%)
ZLAB : 25.86 (-1.41%)
NTBL : 0.2479 (-27.68%)
CRDF : 2.51 (-0.79%)
JNJ : 153.72 (+0.40%)
Rising Number of Studies to Develop Novel Therapies For Pancreatic Ductal Adenocarcinoma (PDAC) Intensely Increasing FinancialNewsMedia - Mon Oct 23, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:CRDF),(NYSE:LLY),(NYSE:ABBV),(NASDAQ:LIPO) EQNX::TICKER_END

ONCY : 0.9863 (-1.22%)
ONC.TO : 1.39 (-0.71%)
CRDF : 2.51 (-0.79%)
LLY : 740.08 (-1.77%)
ABBV : 169.38 (+0.97%)
LIPO : 2.54 (+5.39%)
Wall Street - Nasdaq Times Square
Nasdaq Futures Climb as Bond Yields Retreat From Decade Highs, Micron Earnings on Tap Barchart - Wed Sep 27, 2023

December Nasdaq 100 E-Mini futures (NQZ23) are trending up +0.44% this morning as U.S. Treasury yields slipped from decade highs, while investors braced for a new round of economic data as well as an earnings...

NQZ23 : 16,530.23s (-0.07%)
CTAS : 219.83 (+0.49%)
AAPL : 226.91 (-0.91%)
GOOGL : 164.94 (-6.27%)
AMZN : 199.05 (-1.89%)
DKNG : 43.86 (+0.14%)
MU : 98.70 (+0.34%)
PAYX : 142.33 (+0.35%)
JEF : 76.46 (+2.07%)
HMB.S.DX : 153.100 (-0.02%)
COST : 946.79 (+2.02%)
CHPT : 1.0750 (-1.38%)
Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy PR Newswire - Tue Sep 26, 2023

Pancreatic Cancer Program - Pancreatic cancer Phase 2 trial of onvansertib + SoC in the second-line setting demonstrated greater efficacy vs. historical...

CRDF : 2.51 (-0.79%)
Cardiff Oncology to Present at Upcoming Investor Conferences in September PR Newswire - Tue Sep 5, 2023

/PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug...

CRDF : 2.51 (-0.79%)

Barchart Exclusives

Ambarella Earnings Preview: What to Expect from the Semiconductor Stock in Q3 Barchart - 20 minutes ago
Down almost 80% from all-time highs, Ambarella is a tech stock that trades at a discount to consensus price target estimates. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot